Inhalation Sciences: Order from a long-term client

Research Note

2022-09-05

09:52

Redeye endorses that ISAB has received another order from a leading global pharmaceutical company. We want to highlight that the customer is recurring and believe it validates ISAB’s offering. We reiterate our Base Case and hope to see more sales activity during the fall.

GM

Gustaf Meyer

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.